EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nephros's Enterprise Value is $18.93 Mil.
Nephros's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.57 Mil. Therefore, Nephros's EV-to-EBIT for today is -12.04.
The historical rank and industry rank for Nephros's EV-to-EBIT or its related term are showing as below:
NEPH'
s EV-to-EBIT Range Over the Past 10 Years
Min: -35.09 Med: -9.37 Max: 112.92
Current: -12.04
During the past 13 years, the highest EV-to-EBIT of Nephros was 112.92. The lowest was -35.09. And the median was -9.37.
NEPH's EV-to-EBIT is ranked worse than 100% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 19.09
vs NEPH: -12.04
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Nephros's Enterprise Value for the quarter that ended in Dec. 2023 was $34.01 Mil.
Nephros's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.57 Mil. Nephros's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.63%.
Nephros EV-to-EBIT Historical Data
The historical data trend for Nephros's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Nephros Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-EBIT
-25.42
-18.50
-21.00
-2.97
-21.62
Nephros Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBIT
-2.97
-2.76
-4.83
-7.14
-21.62
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Nephros's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephros EV-to-EBIT Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Nephros's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nephros's EV-to-EBIT falls into.
Nephros's current Enterprise Value is $18.93 Mil.
Nephros's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephros (NAS:NEPH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Nephros's Enterprise Value for the quarter that ended in Dec. 2023 was $34.01 Mil.
Nephros's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephros EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Nephros's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Nephros Inc is a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, it sell water filtration products and waterborne pathogen detection products. In commercial markets, the company manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The operating segments of the group are Water Filtration, Pathogen Detection and Renal Products of which key revenue is derived from Water Filtration segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEPH has been successfully added to your 